Acasti Pharma Stock (NASDAQ:ACST), Quotes and News Summary

Q: What sector and industry does Acasti Pharma (ACST) operate in?

Acasti Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Acasti Pharma Stock (NASDAQ: ACST) stock price, news, charts, stock research, profile.

Open	$2.750
Close	$2.760
Volume / Avg.	4.308K / 26.685K
Day Range	2.730 - 2.860
52 Wk Range	1.720 - 20.660
Market Cap	$25.942M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	0.05%
Days to Cover	1

Recent News

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.

Avi Kapoor

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.

Lisa Levin

Why Acasti Pharma (ACST) Stock Is Exploding Higher

Acasti Pharma Inc (NASDAQ: ACST) shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 million in private placement equity financing.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acasti Pharma (ACST) stock?

You can purchase shares of Acasti Pharma (NASDAQ: ACST) through any online brokerage.

View our list of the best stock brokerages.

Who are Acasti Pharma's (ACST) competitors?

There are no as such competitors for Acasti Pharma.

What is the target price for Acasti Pharma (ACST) stock?

The latest price target for Acasti Pharma (NASDAQ: ACST) was reported by Craig-Hallum on Wednesday, February 7, 2024. The analyst firm set a price target for 6.00 expecting ACST to rise to within 12 months (a possible 117.39% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Acasti Pharma (ACST)?

The stock price for Acasti Pharma (NASDAQ: ACST) is $2.76 last updated May 10, 2024 at 2:21 PM EDT.

Does Acasti Pharma (ACST) pay a dividend?

There are no upcoming dividends for Acasti Pharma.

When is Acasti Pharma (NASDAQ:ACST) reporting earnings?

Acasti Pharma’s Q1 earnings are confirmed for Friday, August 9, 2024.

Is Acasti Pharma (ACST) going to split?

There is no upcoming split for Acasti Pharma.

What sector and industry does Acasti Pharma (ACST) operate in?

Acasti Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.